We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
+16.85%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$13.2B
AUM Growth
+$2.53B
(+24%)
Cap. Flow
+$1B
Cap. Flow
% of AUM
7.59%
Top 10 Holdings %
Top 10 Hldgs %
23.93%
Holding
3,118
New
401
Increased
1,400
Reduced
617
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$120M |
| 2 |
Globe Life
GL
|
+$115M |
| 3 |
MPT
Medical Properties Trust
MPT
|
+$91.5M |
| 4 |
Arch Capital
ACGL
|
+$69.2M |
| 5 |
Amazon
AMZN
|
+$45.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$138M |
| 2 |
GSK
GSK
|
+$98.7M |
| 3 |
Crown Holdings
CCK
|
+$92.3M |
| 4 |
American Water Works
AWK
|
+$54M |
| 5 |
SolarEdge
SEDG
|
+$45.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.64% |
| 2 | Financials | 15.05% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Communication Services | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Tractor Supply
TSCO
$18B
| $3.17M | 0.02% |
112,890
-2,390
| -2% | -$66.9K |
|
402
iShares US Real Estate ETF
IYR
$4.65B
| $3.16M | 0.02% |
36,959
+900
| +2% | +$74.9K |
|
403
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.9B
| $3.15M | 0.02% |
34,399
+19,050
| +124% | +$1.74M |
|
404
Norfolk Southern
NSC
$75.1B
| $3.15M | 0.02% |
13,241
+4,389
| +50% | +$999K |
|
405
State Street SPDR S&P Aerospace & Defense ETF
XAR
$6.49B
| $3.14M | 0.02% |
27,393
-98
| -0.4% | -$9.93K |
|
406
First Trust Large Cap Core AlphaDEX Fund
FEX
$1.61B
| $3.14M | 0.02% |
42,746
-1,028
| -2% | -$70.8K |
|
407
Consolidated Edison
ED
$39.9B
| $3.11M | 0.02% |
43,042
+25,330
| +143% | +$1.97M |
|
408
Parker-Hannifin
PH
$135B
| $3.11M | 0.02% |
11,411
+5,423
| +91% | +$1.34M |
|
409
BP
BP
$107B
| $3.1M | 0.02% |
151,107
-4,587
| -3% | -$86.4K |
|
410
Vanguard Morningstar Large-Cap ETF
VV
$54.3B
| $3.1M | 0.02% |
17,636
+14,847
| +532% | +$2.47M |
|
411
Republic Services
RSG
$65.7B
| $3.1M | 0.02% |
32,178
+11,875
| +58% | +$1.13M |
|
412
Cummins
CMI
$88.7B
| $3.1M | 0.02% |
13,644
+11,200
| +458% | +$2.52M |
|
413
Magna International
MGA
$18.8B
| $3.09M | 0.02% |
43,660
+3,191
| +8% | +$188K |
|
|
BXMX
414
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
| $3.08M | 0.02% |
239,440
+224,360
| +1,488% | +$2.69M |
|
415
Telus
TU
$15.3B
| $3.08M | 0.02% |
155,576
+14,446
| +10% | +$272K |
|
416
Cboe Global Markets
CBOE
$29.9B
| $3.07M | 0.02% |
32,974
+18,412
| +126% | +$1.61M |
|
417
Bio-Techne
TECH
$11.3B
| $3.06M | 0.02% |
38,568
+6,884
| +22% | +$499K |
|
|
WBA
418
DELISTED
Walgreens Boots Alliance
WBA
| $3.06M | 0.02% |
76,708
+29,557
| +63% | +$1.14M |
|
419
Morgan Stanley
MS
$340B
| $3.04M | 0.02% |
44,361
+1,380
| +3% | +$79.2K |
|
|
PPL
420
PPL Corp
PPL
$26.7B
| $3.02M | 0.02% |
106,987
+34,417
| +47% | +$977K |
|
421
Golub Capital BDC
GBDC
$3.42B
| $3M | 0.02% |
212,401
-2,701
| -1% | -$36.9K |
|
422
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
| $2.99M | 0.02% |
32,202
+2,029
| +7% | +$189K |
|
423
Atlassian
TEAM
$37.8B
| $2.97M | 0.02% |
12,708
+7,847
| +161% | +$1.66M |
|
424
ING
ING
$102B
| $2.96M | 0.02% |
313,386
+18,054
| +6% | +$155K |
|
425
Banco Bradesco
BBD
$36.7B
| $2.96M | 0.02% |
679,989
+37,053
| +6% | +$135K |
|
Similar funds
NAMI
Rockefeller Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Rockefeller Capital Management held 3,118 positions worth $13.2B, up 24% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Rockefeller Capital Management deployed $1B of net new capital in Q4 2020, opening 401 new positions and adding to 1,400 existing holdings. Its largest new stake was BridgeBio Pharma: 777,031 shares worth $55.3M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Progressive, an estimated $138M trimmed.
- Rockefeller Capital Management's largest Q4 2020 buy was BridgeBio Pharma: 777,031 shares worth $55.3M.
- Rockefeller Capital Management added most to Alibaba in Q4 2020, an estimated $120M increase.
- Rockefeller Capital Management's biggest Q4 2020 reduction was Progressive, cutting an estimated $138M.
- Rockefeller Capital Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $1.67M.
- Rockefeller Capital Management's ten largest holdings make up 24% of its $13.2B portfolio in Q4 2020.
- Rockefeller Capital Management opened 401 new positions and closed 168 in Q4 2020.
- Rockefeller Capital Management's portfolio value rose 24% quarter-over-quarter to $13.2B.
Based on Rockefeller Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.